Score Overview
Integra LifeSciences Holdings fundamental performance
Between 2005 and 2025, revenue grew from $ 277M to $ 1.63B and net income went from $ 37M to -$ 516M. Revenue increased in 17 of those 20 years; net income in 11.
Across Integra LifeSciences Holdings's full reported history, from 1995 to 2025, revenue grew from $ 10M to $ 1.63B and net income went from -$ 25M to -$ 516M. Revenue increased in 90% of the years measured; net income in 55%.
Integra LifeSciences Holdings currently holds a 20-year HDB Score of 4.8 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 17.38 | — |
1 Year2025-08-12 | $ 13.77 | 26.22% |
5 Years2021-08-12 | $ 70.94 | -75.50% |
10 Years2016-08-12 | $ 41.86 | -58.48% |
20 Years2006-08-11 | $ 12.66 | 37.31% |
30 Years1996-08-12 | $ 3.47 | 400.78% |
All Time1995-08-16 | $ 3.29 | 427.85% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | 20 Years2006-08-11 | 30 Years1996-08-12 | All Time1995-08-16 |
|---|---|---|---|---|---|---|---|
| Price | $ 17.38 | $ 13.77 | $ 70.94 | $ 41.86 | $ 12.66 | $ 3.47 | $ 3.29 |
| Return | — | 26.22% | -75.50% | -58.48% | 37.31% | 400.78% | 427.85% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 1.64B | -$ 7M | $ 274M |
| 2025 | $ 1.63B | -$ 516M | $ 263M |
| 2024 | $ 1.61B | -$ 6M | $ 273M |
| 2023 | $ 1.54B | $ 67M | $ 309M |
| 2022 | $ 1.55B | $ 180M | $ 456M |
| 2021 | $ 1.54B | $ 169M | $ 513M |
| 2020 | $ 1.37B | $ 133M | $ 470M |
| 2019 | $ 1.51B | $ 50M | $ 198M |
| 2018 | $ 1.47B | $ 60M | $ 138M |
| 2017 | $ 1.18B | $ 64M | $ 174M |
| 2016 | $ 992M | $ 74M | $ 102M |
| 2015 | $ 882M | -$ 3M | $ 48M |
| 2014 | $ 928M | $ 34M | $ 71M |
| 2013 | $ 836M | -$ 16M | $ 120M |
| 2012 | $ 830M | $ 41M | $ 96M |
| 2011 | $ 780M | $ 27M | $ 100M |
| 2010 | $ 732M | $ 65M | $ 128M |
| 2009 | $ 682M | $ 50M | $ 71M |
| 2008 | $ 654M | $ 34M | $ 183M |
| 2007 | $ 550M | $ 33M | $ 57M |
| 2006 | $ 419M | $ 29M | $ 22M |
| 2005 | $ 277M | $ 37M | $ 127M |
| 2004 | $ 229M | $ 17M | $ 100M |
| 2003 | $ 185M | $ 26M | $ 108M |
| 2002 | $ 112M | $ 35M | $ 98M |
| 2001 | $ 93M | $ 26M | $ 66M |
| 2000 | $ 64M | -$ 11M | $ 15M |
| 1999 | $ 42M | -$ 6M | $ 23M |
| 1998 | $ 17M | -$ 12M | $ 5M |
| 1997 | $ 14M | -$ 17M | $ 2M |
| 1996 | $ 13M | -$ 7M | $ 11M |
| IPO1995 | $ 10M | -$ 25M | $ 4M |
Explore beyond IART
You're looking at Integra LifeSciences Holdings. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
